Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

Université de Sherbrooke

$379,077.00

Optimal VAsopressor TItratiON (OVATION) Pilot Randomized controlled Trial

EF 2012-13

Résumé
Patients who are admitted to intensive care units commonly suffer from illnesses that cause life-threatening low blood pressure. In this context, intensivists (physicians who care for patients in intensive care units) administer potent medications that increase blood pressure. Unfortunately, these medications cause adverse effects and it is not clear that they are better than the condition they are meant to treat. In this study, we intend to demonstrate the feasibility of a larger study that will investigate if administering medications to achieve higher blood pressures (that are near normal) is preferable to restricting the use of these medications by tolerating lower blood pressures. Patients will randomly receive blood pressure increasing medications for a higher or lower blood pressure target. In the definitive study, we will compare 90-day survival between groups but in this pilot study, we will validate that it is feasible to adhere to the protocol and achieve a different average blood pressure in each group while on study medication. This study is an important part of a research program that has the potential to change how we administer dangerous medications to the sickest of the sick in our hospitals - ultimately leading to safer, better patient care.
Programme
Operating Grant
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
267561
Name
Lamontagne Francois
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Optimal VAsopressor TItratiON (OVATION) Pilot Randomized controlled Trial
Programtype2
Operating Grants
Orgnameinp2
Université de Sherbrooke
Cihramount2
$379,077
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Pilot Study; Randomized Controlled Trial; Shock; Titration; Vasopressors
Abstract
Patients who are admitted to intensive care units commonly suffer from illnesses that cause life-threatening low blood pressure. In this context, intensivists (physicians who care for patients in intensive care units) administer potent medications that increase blood pressure. Unfortunately, these medications cause adverse effects and it is not clear that they are better than the condition they are meant to treat. In this study, we intend to demonstrate the feasibility of a larger study that will investigate if administering medications to achieve higher blood pressures (that are near normal) is preferable to restricting the use of these medications by tolerating lower blood pressures. Patients will randomly receive blood pressure increasing medications for a higher or lower blood pressure target. In the definitive study, we will compare 90-day survival between groups but in this pilot study, we will validate that it is feasible to adhere to the protocol and achieve a different average blood pressure in each group while on study medication. This study is an important part of a research program that has the potential to change how we administer dangerous medications to the sickest of the sick in our hospitals - ultimately leading to safer, better patient care.
Competitiondate
201209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Lamontagne, Francois; Hebert, Paul C
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $379,077~ $0~